Mark Levine

6.5k total citations · 1 hit paper
54 papers, 4.1k citations indexed

About

Mark Levine is a scholar working on Internal Medicine, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Mark Levine has authored 54 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Internal Medicine, 18 papers in Cardiology and Cardiovascular Medicine and 14 papers in Surgery. Recurrent topics in Mark Levine's work include Venous Thromboembolism Diagnosis and Management (23 papers), Atrial Fibrillation Management and Outcomes (13 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (6 papers). Mark Levine is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (23 papers), Atrial Fibrillation Management and Outcomes (13 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (6 papers). Mark Levine collaborates with scholars based in United States, Canada and France. Mark Levine's co-authors include Jack Hirsh, Michael Gent, Gary E. Raskob, Peter Powers, Jeffrey I. Weitz, Jeffrey S. Ginsberg, Jacques Leclerc, William Geerts, Seth Landefeld and Samuel Z. Goldhaber and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Mark Levine

48 papers receiving 3.9k citations

Hit Papers

A Comparison of Low-Molec... 1996 2026 2006 2016 1996 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. A Comparison of Low-Molecular-Weight Heparin Administered Primarily at Home with Unfractionated Heparin Administered in the Hospital for Proximal Deep-Vein Thrombosis
    1996 872 citations Mark Levine, Michael Gent et al. New England Journal of Medicine profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Mark Levine 2.4k 2.0k 1.1k 764 560 54 4.1k
Roopen Arya 1.5k 0.6× 1.1k 0.6× 863 0.8× 243 0.3× 903 1.6× 155 3.6k
Patrick Mismetti 2.9k 1.2× 2.2k 1.1× 1.0k 0.9× 328 0.4× 628 1.1× 154 4.2k
Renate Koppensteiner 1.1k 0.4× 2.1k 1.1× 2.3k 2.0× 1.8k 2.4× 467 0.8× 245 5.6k
Corinne Frère 1.1k 0.5× 2.5k 1.2× 1.3k 1.2× 281 0.4× 625 1.1× 122 4.3k
Lesley Mitchell 2.3k 1.0× 1.2k 0.6× 1.1k 1.0× 671 0.9× 3.2k 5.7× 119 5.2k
C.D. Forbes 846 0.3× 1.4k 0.7× 676 0.6× 1.1k 1.5× 805 1.4× 128 3.8k
Thomas M. Hyers 3.2k 1.3× 2.3k 1.2× 1.6k 1.4× 2.7k 3.5× 850 1.5× 73 7.0k
Claudio Cimminiello 1.2k 0.5× 2.1k 1.1× 1.0k 0.9× 825 1.1× 269 0.5× 104 3.5k
Mariano Valdés 1.2k 0.5× 5.6k 2.8× 1.7k 1.5× 760 1.0× 212 0.4× 296 7.8k
Henry G. Watson 1.2k 0.5× 1.1k 0.5× 559 0.5× 168 0.2× 910 1.6× 37 3.0k

Countries citing papers authored by Mark Levine

Since Specialization
Citations

This map shows the geographic impact of Mark Levine's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Levine with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Levine more than expected).

Fields of papers citing papers by Mark Levine

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Levine. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Levine. The network helps show where Mark Levine may publish in the future.

Co-authorship network of co-authors of Mark Levine

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Levine. A scholar is included among the top collaborators of Mark Levine based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Levine. Mark Levine is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Levine, Mark. (2020). WOMEN OF OVID’S ARS AM A TO R IA : NATURE OR CULTURE?. Scripta classica Israelica. 6. 30–56.
3.
Andronesi, Ovidiu C., Katharine Nicholson, Kourosh Jafari‐Khouzani, et al.. (2020). Imaging Neurochemistry and Brain Structure Tracks Clinical Decline and Mechanisms of ALS in Patients. Frontiers in Neurology. 11. 590573–590573. 19 indexed citations
4.
Levine, Mark, et al.. (2007). Difficultés d’observance dans les maladies chroniques à l’adolescence : comprendre pour agir. Archives de Pédiatrie. 15(1). 89–94. 17 indexed citations
5.
Levine, Mark, Michael Keeney, Karen MacKinnon, Agnes Lee, & Michael J. Kovacs. (2005). Anti-Xa effect of a low molecular weight heparin (dalteparin) does not accumulate in extended duration therapy for venous thromboembolism in cancer patients. Thrombosis and Haemostasis. 93(6). 1185–1188. 14 indexed citations
6.
Corpe, Christopher, J. H. Hoekstra, Ian A. Simpson, et al.. (2002). Cloning and functional characterization of the mouse fructose transporter, GLUT5. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 1576(1-2). 191–197. 51 indexed citations
7.
Pinnell, Sheldon R., et al.. (2001). Topical L-Ascorbic Acid: Percutaneous Absorption Studies. Dermatologic Surgery. 27(2). 137–142. 159 indexed citations
8.
Levine, Mark, Y. Wang, & Steven C. Rumsey. (1999). [6]Analysis of ascorbic acid and dehydroascorbic acid in biological samples. Methods in enzymology on CD-ROM/Methods in enzymology. 299. 65–76. 60 indexed citations
9.
Levine, Mark, Andrew R. Willan, Ron Goeree, et al.. (1999). Economic Evaluation of Outpatient Treatment With Low-Molecular-Weight Heparin for Proximal Vein Thrombosis. Archives of Internal Medicine. 159(19). 2298–304. 96 indexed citations
10.
Levine, Mark, Gary E. Raskob, Seth Landefeld, & Clive Kearon. (1998). Hemorrhagic Complications of Anticoagulant Treatment. CHEST Journal. 114(5). 511S–523S. 92 indexed citations
11.
Mintz, Arlan, John R. W. Kestle, Michel P. Rathbone, et al.. (1996). A randomized trial to assess the efficacy of surgery in addition to radiotherapy in patients with a single cerebral metastasis. Cancer. 78(7). 1470–1476. 473 indexed citations
12.
Levine, Mark, Michael Gent, Jack Hirsh, et al.. (1996). A Comparison of Low-Molecular-Weight Heparin Administered Primarily at Home with Unfractionated Heparin Administered in the Hospital for Proximal Deep-Vein Thrombosis. New England Journal of Medicine. 334(11). 677–681. 872 indexed citations breakdown →
13.
Block, Gladys, Jeffrey B. Blumberg, A. T. Diplock, et al.. (1994). Summary of the round table discussion on strategies for cancer prevention: diet, food, additives, supplements, and drugs.. PubMed. 54(7 Suppl). 2044s–2051s. 27 indexed citations
14.
Turpie, Alexander G.G., Michael Gent, Mark Levine, et al.. (1992). A Low-Molecular-Weight Heparinoid Compared with Unfractionated Heparin in the Prevention of Deep Vein Thrombosis in Patients with Acute Ischemic Stroke. Annals of Internal Medicine. 117(5). 353–357. 84 indexed citations
15.
Henson, Donald E., Gladys Block, & Mark Levine. (1991). Ascorbic Acid: Biologic Functions and Relation to Cancer. JNCI Journal of the National Cancer Institute. 83(8). 547–550. 74 indexed citations
16.
Washko, Philip W., Daniel Rotrosen, & Mark Levine. (1990). Ascorbic acid accumulation in plated human neutrophils. FEBS Letters. 260(1). 101–104. 17 indexed citations
17.
18.
Fennerty, A G & Mark Levine. (1989). Non-biological factors in day to day variation of heparin requirements.. BMJ. 299(6706). 1012–1013. 2 indexed citations
19.
Grumbach, K, H Herlinger, Igor Laufer, & Mark Levine. (1988). Metoclopramide - Ceruletide-assisted small bowel examination. RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren. 149(7). 47–51. 1 indexed citations
20.
Weitz, Jeffrey I., Moira Cruickshank, Bob Thong, et al.. (1988). Human tissue-type plasminogen activator releases fibrinopeptides A and B from fibrinogen.. Journal of Clinical Investigation. 82(5). 1700–1707. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Roopen Arya Breakdown of academic impact, for papers by Patrick Mismetti Breakdown of academic impact, for papers by Renate Koppensteiner Breakdown of academic impact, for papers by Corinne Frère Breakdown of academic impact, for papers by Lesley Mitchell Breakdown of academic impact, for papers by C.D. Forbes Breakdown of academic impact, for papers by Thomas M. Hyers Breakdown of academic impact, for papers by Claudio Cimminiello Breakdown of academic impact, for papers by Mariano Valdés Breakdown of academic impact, for papers by Henry G. Watson
Rankless by CCL
2026